Biotricity Completes $12 Million Non-Dilutive Debt Financing
Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms5-year term deal strengthens...
News
Todos Medical Records Record Weekly COVID PCR Testing Volumes at Provista
cPass neutralizing antibody testing seeing increasing demand, questions of infection-acquired immunity, vaccine-acquired immunity and booster shot durability emergeThe Company also...
Sorrento Therapeutics Mexico Executes Second Contract for Sale of 10 Million COVISTIX Tests for Mexico Market
SAN DIEGO and MEXICO CITY, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, “Sorrento”) announced today its...
Castellum Announces Signing of LOI to Acquire $4 Million Government Contractor
Castellum Announces Signing of LOI to Acquire $4 million government contractor Castellum, Inc. (OTC: ONOV) announces the signing of a...
Faraday Pharmaceuticals Announces Publication of Results from its Phase 2 Study of FDY-5301 for the Treatment of Reperfusion Injury Following a STEMI Heart Attack
To be Published in the International Journal of CardiologySEATTLE, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Faraday Pharmaceuticals, Inc., a muscle...
Metacrine Announces Resignation of Chief Medical Officer
SAN DIEGO, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients...
Revolo Biotherapeutics Announces the Appointment of Tunde Otulana, M.D., to its Board of Directors
NEW ORLEANS and LONDON, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Revolo Biotherapeutics (“Revolo Bio” or the “Company”), a Company developing...
TRACON Pharmaceuticals Announces Positive Results from the Independent Data Monitoring Committee Review of Interim Safety and Efficacy Data from the Ongoing ENVASARC Pivotal Trial
Pre-specified Interim Analysis Concluded with Recommendation to Continue the ENVASARC Trial Objective Response Rate (ORR) by Blinded Independent Central Review...
Celularity Receives Fast Track Designation from U.S. FDA for its NK Cell Therapy CYNK-001 in Development for the Treatment of AML
FLORHAM PARK, N.J., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) (“Celularity”), a clinical-stage biotechnology company developing placental-derived...
Microbot Medical Announces Strategic Collaboration with Stryker Corporation to Develop the LIBERTY® Robotic System for Neurovascular Applications
HINGHAM, Mass., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced that it has entered into a...
Aclaris Therapeutics to Participate in the H.C. Wainwright BioConnect Virtual Conference
WAYNE, Pa., Dec. 27, 2021 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing...
Pluristem Reports Topline Results from its Phase II Studies of Acute Respiratory Distress Syndrome Associated with COVID-19
HAIFA, Israel, Dec. 27, 2021 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI) (the “Company”), a leading biotechnology company, today...
Pardes Biosciences Debuts as a Publicly Traded Company Focused on Oral Antiviral Therapies to Potentially Treat and Prevent COVID-19
Pardes Biosciences Main Protease Pardes Biosciences Main Protease PBI-0451 Pardes Biosciences PBI-0451 Oral Antiviral Pill Pardes NASDAQ Listing Pardes Biosciences...
BridgeBio Pharma Reports Month 12 Topline Results from Phase 3 ATTRibute-CM Study
- ATTRibute-CM did not meet its primary endpoint at Month 12. Mean observed six-minute walk distance (6MWD) decline for the...
BioNTech to Present at the 40th Annual J.P. Morgan Healthcare Conference
MAINZ, Germany, December 27, 2021 — BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced today that CEO and Co-founder...
Terranueva Obtains a Refinancing
L’ASSOMPTION, Quebec, Dec. 24, 2021 (GLOBE NEWSWIRE) -- Terranueva Corporation (CSE: TEQ) ("Terranueva" or the "Company") is pleased to announce...
Roche COVID-19 At-Home Test granted FDA Emergency Use Authorization to expand access to rapid self-testing solutions in the United States
Rapid test to support the American public’s fight against the COVID-19 pandemic, with availability to purchase over-the-counter (OTC) at pharmacies...
Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021
Company announcement – No. 77 / 2021 Zealand Pharma major shareholder announcement: The Capital Group Companies, 2021 Copenhagen, DK and Boston,...
Letter of Intent for Merger Between Phoenix Life Sciences and ArCare Holdings Sdn Bhd
LAS VEGAS, NV / ACCESSWIRE / December 24, 2021 / Phoenix Life Sciences International Limited, ("PLSI") (OTC PINK:PLSI) a publicly-traded...
Glow LifeTech Announces Commencement of Clinical Study of Artemic Support Featuring MyCell Technology on Patients with Long COVID
Toronto, Ontario--(Newsfile Corp. - December 24, 2021) - Glow LifeTech Corp. (CSE: GLOW) (OTCQB: GLWLF) (FSE: 9DO) ("Glow" or the...